Viewing Study NCT01894256

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-05-18 @ 2:31 AM
Study NCT ID: NCT01894256
Status: COMPLETED
Last Update Posted: 2016-10-13
First Post: 2013-07-04
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None oncology, View
None cancer, View
None neoplasm, View
None anticancer drug, View
None pharmacokinetics, View
None area under curve, View
None olaparib, View
None solid tumour, View
None mild renal impairment, View
None moderate renal impairment View